Chronic fatigue and long Covid remain poorly understood, but Dr Perrin’s unusual techniques are having surprisingly positive ...

The best window for recovery is in the first six months after getting COVID-19, with better odds for people whose initial ...

Chronic fatigue isn’t always a result of lifestyle factors—it can be a signal from your nervous system that something is off ...

Aim Immunotech Inc. ( (AIM) ) has released its Q3 earnings. Here is a breakdown of the information Aim Immunotech Inc. presented to its ...

Recent scientific studies suggest the longer someone is sick, the lower their chances of making a full recovery ...

Vitamin C may be one of the top potential supplements to reduce cortisol and is readily abundant in several formats. However, ...

XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Positive Results from Six-Month Phase 2 Trial of Mavorixafor in ...

The family of a Black sickle cell patient who died “naked and alone” in prison after a medical crisis have described their ...

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...